Clinical options for the reduction of elevated intraocular pressure.
File(s)
Author(s)
Crawley, Laura
Zamir, Sohaib M
Cordeiro, Maria F
Guo, Li
Type
Journal Article
Abstract
Elevated IOP in clinical practice is usually seen in glaucoma or ocular hypertension. Glaucoma affects 60 million people worldwide and 8.4 million are bilaterally blind from this chronic disease.1 Options for reducing IOP rely on pharmacological agents, laser treatments and surgery which may be penetrating or non-penetrating. The last twenty years has seen significant changes in all of these strategies. This review aims to cover these clinical options and introduce some of the new technologies currently in development for the clinical lowering of IOP.
Date Issued
2012-01-01
Date Acceptance
2012-01-01
Citation
Ophthalmol Eye Dis, 2012, 4, pp.43-64
ISSN
1179-1721
Publisher
SAGE
Start Page
43
End Page
64
Journal / Book Title
Ophthalmol Eye Dis
Volume
4
Copyright Statement
© the author(s), publisher and licensee Libertas Academica Ltd.
This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited
This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/23650457
PII: oed-4-2012-043
Subjects
glaucoma
laser
ocular hypertension
pharmacological agents
reducing IOP
surgery
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2012-04-30